Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
New GPNMB CAR-T cell therapy shows potential to treat aggressive glioblastoma by targeting both tumors and their immune cell accomplices.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
An immunotherapy strategy developed at the University of Calgary and McMaster used CAR T cells to simultaneously target glioblastoma and immune cells. The treatment showed promise in reducing rare cancerous tumors and eliminating aggressive brain cancer.
Epilogue added 16d ago, after coverage quieted.
The brief
Researchers are developing an immunotherapy strategy using GPNMB CAR-T cells to combat glioblastoma. This approach utilizes cytokine-armoured therapy to target aggressive brain tumors and the myeloid cells that assist them.
Coverage from Nature, Medical Xpress, and News-Medical emphasizes the potential for this dual-targeting method to eliminate aggressive tumors. The Telegraph describes the target as the deadliest form of brain cancer.
Future developments will focus on the efficacy of this immunotherapy strategy and the performance of the cytokine-armoured CAR T cells in treating these brain tumors.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 21d ago.
Quick answers
What specific cells are being used in this therapy?
The therapy utilizes GPNMB CAR-T cells.
What makes this immunotherapy strategy different?
It employs a dual tumour–myeloid targeting approach, focusing on both the tumors and their immune cell accomplices.
What is the primary target of this treatment?
The treatment targets aggressive glioblastoma, a form of brain cancer.
Coverage (15)
- Beeta Benjy: What is the Missing Puzzle Piece of CAR-T Therapy Failure in Solid Tumors? Oncodaily · 21d ago
- Engineered Immunotherapy Improves Treatment for Brain Cancer Labroots · 21d ago
- CAR T Cells Simultaneously Target Glioblastoma and Immune Cells Inside Precision Medicine · 21d ago
- New Therapy Could Target One of the Deadliest Brain Cancers Newsweek · 21d ago
- Community giving powers a UCalgary cancer immunotherapy breakthrough University of Calgary · 21d ago
- U of C-developed experimental treatment reduces rare cancerous tumours Calgary Herald · 21d ago
- New immunotherapy developed at the University of Calgary being used to treat solid cancerous tumours University of Calgary · 21d ago
- With GPNMB, CAR T makes further inroads in solid tumors BioWorld News · 21d ago
- McMaster-Developed Immunotherapy Strategy Targets Aggressive Brain Tumours and Their Fuel Newswise · 21d ago
- Immunotherapy Strategy Shows Promise for Deadly Brain Cancer Northwestern University · 21d ago
- CAR-T cell therapy shows potential to eliminate aggressive glioblastoma News-Medical · 21d ago
- Cytokine-armoured CAR T therapy shows promise against aggressive glioblastoma Labmate-Online · 21d ago
- New immunotherapy strategy targets aggressive brain tumors and their immune cell accomplices Medical Xpress · 21d ago
- Deadliest brain cancer could be treated with immunotherapy The Telegraph · 21d ago
- Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells Nature · 21d ago
Topics
Related trends
Thymulin restrains age-associated myeloid inflammation and enhances cancer immunotherapy
Research suggests the hormone thymulin may suppress age-related inflammation and improve the effectiveness of cancer immunotherapy.
Brain tumors: New vaccine offers patients hope for more time
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
The cheap supplement that scientists believe could help fight cancer
Scientists are investigating whether the affordable workout supplement creatine can assist in the fight against cancer.
Largest study yet reveals which cancers have their own microbiomes
A large-scale study has identified specific microbiomes residing within cancer tumors, signaling a shift in how oncology researchers view microbial interactions.
Alzheimer's: BCG vaccine may reshape brain immune response
New clinical trial data suggests the tuberculosis BCG vaccine may reduce Alzheimer's risk by remodeling the brain's immune environment.
Scientists Just Unlocked an Endless Army of Cancer-Fighting Cells
Scientists at USC have developed a technique to create an endless supply of cancer-fighting immune cells by enabling progenitor cells to self-renew.